Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Inclusion Criteria

• •Triple Negative Breast Cancer
• •ER/PR \<10% and HER negative per current ASCO/CAP guidelines
• •Stages I-IV
• •Any age at diagnosis
• •Patient must be within 5 years of diagnosis
• •Eligible regardless of genetic testing status
• •Genetic testing recommended for patients meeting NCCN and Medicare guidelines
• •AND/OR
• •Germline mutation Carriers
• •Patients with deleterious or uncertain mutations in HBOC genes (BRCA, PTEN, P53, -PALB2 etc) are eligible regardless of type/site of cancer
• •Healthy patients harboring mutations also eligible
• •There is no time limit from the time of diagnosis of cancer and enrollment.
• •Eligible regardless of personal history of cancer